From the Guidelines
The most recent guidelines for Non-Communicable Diseases (NCD) emphasize the importance of physical activity (PA) and provide evidence-based recommendations for adults with NCDs, aiming to achieve significant health outcomes through targeted doses of PA. When considering the management of NCDs, several key points emerge from recent studies, including the German recommendations for physical activity and physical activity promotion in adults with noncommunicable diseases 1. These guidelines highlight the development of PA recommendations for adults with NCDs as a crucial step in health promotion, providing a specific target dose of PA that can lead to significant health benefits. Some of the key aspects of these recommendations include:
- The development of evidence-based PA and PA promotion guidelines as a fundamental building block for initiating and implementing health promotion actions
- The uniqueness of the German recommendations in providing specific PA recommendations for adults with NCDs, combined with tailored PA promotion strategies
- The potential for these guidelines to serve as a model for other nations in developing their own PA guidelines for adults with NCDs. Given the emphasis on evidence-based practice and the importance of physical activity in managing NCDs, healthcare providers should prioritize recommending and promoting physical activity as part of a comprehensive approach to NCD management, based on the most recent and highest quality evidence available, such as the German recommendations from 2020 1. In clinical practice, this may involve assessing the patient's current level of physical activity, setting achievable goals for increasing PA, and providing resources and support to help patients meet these goals, all while considering the individual's specific NCD and overall health status.
From the Research
Recent Guidelines on Non-Communicable Diseases (NCD)
There are no research papers to assist in answering this question as the provided studies focus on neurocysticercosis, a parasitic infection, rather than Non-Communicable Diseases (NCD).
Neurocysticercosis Treatment Guidelines
- The diagnosis of neurocysticercosis should be based on clinical history and neuroimaging, with contrast-enhanced magnetic resonance imaging of the brain being the modality of choice 2.
- For single enhancing lesion, albendazole therapy for 10-14 days is recommended, and it should be combined with praziquantel for 10-14 days for more than one ring-enhancing lesions 2.
- Pulse intravenous steroids should be used to reduce the acute symptomatic edema in children with cysticercal encephalitis 2.
- Carbamazepine or oxcarbazepine are best suited for seizure prophylaxis for those who present with seizures; phenytoin and levetiracetam are the other alternatives 2.
Experimental Neurocysticercosis Treatment
- A combination of albendazole and ivermectin has been shown to decrease inflammation in experimental neurocysticercosis, with potential to decrease the negative effects of the inflammatory burst when the parasite is killed within the CNS 3.
- The combination of albendazole and praziquantel increases the parasiticidal effect in patients with multiple brain cysticercosis cysts without increased side-effects 4.